|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2004
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
1 Dept of Respiratory Medicine, Leeds General Infirmary, and 2 Dept of Communicable Disease Control, Leeds Health Authority, Leeds, UK
CORRESPONDENCE: M.T. Henry, Dept of Respiratory Medicine, Leeds General Infirmary, Leeds LS1 3EX, UK. Fax: 44 1133926316. E-mail: michael.henry@leedsth.nhs.uk
Keywords: Epidemiology, nontuberculous mycobacterium, response-to-treatment guidelines
Received: October 12, 2003
Accepted January 23, 2004
Recent international guidelines published in 1997 and 1999 have proposed diagnostic and treatment criteria for disease caused by nontuberculous mycobacteria (NTM).
In this paper, the epidemiological data, diagnostic criteria, treatment regimens and outcomes from 117 HIV-negative patients who had a positive culture for NTM between 1995–1999 are reviewed. The authors wished to identify factors associated with improved outcome in these patients.
A total of 71 patients were believed to have a clinical disease caused by NTM, as defined by international criteria. A total of 72% patients were found to have had pulmonary disease. There was a rise in infections between 1995–1999, with a peak in infections in 1997. The most striking rise was in Mycobacterium avium intracellulare complex infections (1995: 33% infections; 1996: 36% infections; 1997: 41% infections; 1998: 61% infections; 1999: 57% infections). There was a link between deprivation and number of positive NTM isolates (34.4% isolates occurred in the areas of lowest Carstairs deprivation index versus 20.6% isolates from areas of least deprivation). There was a significant association between appropriate therapy, defined by American Thoracic Society and British Thoracic Society guidelines, and successful outcome (74%) in contrast to those who received inappropriate treatment prior to the publication of these guidelines.
Nontuberculous mycobacteria infections remain a significant problem in non-HIV patients. Adherence to published guidelines may improve patient outcomes.
This article has been cited by other articles:
|
|
 |
|
  W. Hoefsloot, J. van Ingen, W. C. M. de Lange, P. N. R. Dekhuijzen, M. J. Boeree, and D. van Soolingen Clinical relevance of Mycobacterium malmoense isolation in the Netherlands Eur. Respir. J., October 1, 2009; 34(4): 926 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ichikawa, T. Yagi, M. Moriyama, T. Inagaki, T. Nakagawa, K.-I. Uchiya, T. Nikai, and K. Ogawa Characterization of Mycobacterium avium clinical isolates in Japan using subspecies-specific insertion sequences, and identification of a new insertion sequence, ISMav6 J. Med. Microbiol., July 1, 2009; 58(7): 945 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J van Ingen, S A Bendien, W C M de Lange, W Hoefsloot, P N R Dekhuijzen, M J Boeree, and D van Soolingen Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands Thorax, June 1, 2009; 64(6): 502 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van Ingen, M. J. Boeree, W. C. M. de Lange, P. E. W. de Haas, A. G. M. van der Zanden, W. Mijs, L. Rigouts, P. N. R. Dekhuijzen, and D. van Soolingen Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients Int J Syst Evol Microbiol, April 1, 2009; 59(4): 845 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Sampaio, H. Z. Elloumi, A. Zelazny, L. Ding, M. L. Paulson, A. Sher, A. L. Bafica, Y. R. Shea, and S. M. Holland Mycobacterium abscessus and M. avium Trigger Toll-Like Receptor 2 and Distinct Cytokine Response in Human Cells Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 431 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kuroishi, Y. Nakamura, H. Hayakawa, M. Shirai, Y. Nakano, K. Yasuda, T. Suda, H. Nakamura, and K. Chida Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings Eur. Respir. J., July 1, 2008; 32(1): 147 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ichimura, M. Nagano, N. Ito, M. Shimojima, T. Egashira, C. Miyamoto, K. Ohkusu, and T. Ezaki Evaluation of the Invader Assay with the BACTEC MGIT 960 System for Prompt Isolation and Identification of Mycobacterial Species from Clinical Specimens J. Clin. Microbiol., October 1, 2007; 45(10): 3316 - 3322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. McGrath and N. Qureshi Mycobacterium chelonei: friend or foe? Eur. Respir. J., August 1, 2007; 30(2): 397 - 397. [Full Text] [PDF]
|
|
|
|
|
|
G. Tanaka, J. Shojima, I. Matsushita, H. Nagai, A. Kurashima, K. Nakata, E. Toyota, N. Kobayashi, K. Kudo, and N. Keicho Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphisms Eur. Respir. J., July 1, 2007; 30(1): 90 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dailloux, M. L. Abalain, C. Laurain, L. Lebrun, C. Loos-Ayav, A. Lozniewski, J. Maugein, and the French Mycobacteria Study Group Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients Eur. Respir. J., December 1, 2006; 28(6): 1211 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Vazquez, T. Greenwell-Wild, S. Rekka, J. M. Orenstein, and S. M. Wahl Mycobacterium avium-induced SOCS contributes to resistance to IFN-{gamma}-mediated mycobactericidal activity in human macrophages J. Leukoc. Biol., November 1, 2006; 80(5): 1136 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Field and R. L. Cowie Lung Disease Due to the More Common Nontuberculous Mycobacteria Chest, June 1, 2006; 129(6): 1653 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Koh, O. J. Kwon, K. Jeon, T. S. Kim, K. S. Lee, Y. K. Park, and G. H. Bai Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest, February 1, 2006; 129(2): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |